Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis

M. Pardeo; J. Wang; N. Ruperto; E. Alexeeva; V. Chasnyk; R. Schneider; G. Horneff; H.-I. Huppertz; K. Minden; K. Onel; L. Zemel; A. Martin; I. Koné-Paut; A. Siamopoulou-Mavridou; C.A. Silva; B. Porter-Brown; K.N. Bharucha; H.I. Brunner; F. De Benedetti; for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG)

doi:10.3899/jrheum.180795

Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis

M. Pardeo, J. Wang, N. Ruperto, E. Alexeeva, V. Chasnyk, R. Schneider, G. Horneff, H.-I. Huppertz, K. Minden, K. Onel, L. Zemel, A. Martin, I. Koné-Paut, A. Siamopoulou-Mavridou, C.A. Silva, B. Porter-Brown, K.N. Bharucha, H.I. Brunner, F. De Benedetti, for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG)

Istituto "Giannina Gaslini"

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	1117-1126
Number of pages	10
Journal	Journal of Rheumatology
Volume	46
Issue number	9
DOIs	https://doi.org/10.3899/jrheum.180795
Publication status	Published - 2019

Cite this

Pardeo, M., Wang, J., Ruperto, N., Alexeeva, E., Chasnyk, V., Schneider, R., ... (PRCSG), F. T. P. R. I. T. O. PRINTO. A. T. P. R. C. S. G. (2019). Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis. Journal of Rheumatology, 46(9), 1117-1126. https://doi.org/10.3899/jrheum.180795

Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis. / Pardeo, M.; Wang, J.; Ruperto, N.; Alexeeva, E.; Chasnyk, V.; Schneider, R.; Horneff, G.; Huppertz, H.-I.; Minden, K.; Onel, K.; Zemel, L.; Martin, A.; Koné-Paut, I.; Siamopoulou-Mavridou, A.; Silva, C.A.; Porter-Brown, B.; Bharucha, K.N.; Brunner, H.I.; De Benedetti, F.; (PRCSG), for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group.

In: Journal of Rheumatology, Vol. 46, No. 9, 2019, p. 1117-1126.

Research output: Contribution to journal › Article

Pardeo, M, Wang, J, Ruperto, N, Alexeeva, E, Chasnyk, V, Schneider, R, Horneff, G, Huppertz, H-I, Minden, K, Onel, K, Zemel, L, Martin, A, Koné-Paut, I, Siamopoulou-Mavridou, A, Silva, CA, Porter-Brown, B, Bharucha, KN, Brunner, HI, De Benedetti, F & (PRCSG), FTPRITOPRINTOATPRCSG 2019, 'Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis', Journal of Rheumatology, vol. 46, no. 9, pp. 1117-1126. https://doi.org/10.3899/jrheum.180795

Pardeo, M. ; Wang, J. ; Ruperto, N. ; Alexeeva, E. ; Chasnyk, V. ; Schneider, R. ; Horneff, G. ; Huppertz, H.-I. ; Minden, K. ; Onel, K. ; Zemel, L. ; Martin, A. ; Koné-Paut, I. ; Siamopoulou-Mavridou, A. ; Silva, C.A. ; Porter-Brown, B. ; Bharucha, K.N. ; Brunner, H.I. ; De Benedetti, F. ; (PRCSG), for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group. / Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis. In: Journal of Rheumatology. 2019 ; Vol. 46, No. 9. pp. 1117-1126.

@article{5767f027f3e543a3bad41c9e4fb71f07,

title = "Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis",

author = "M. Pardeo and J. Wang and N. Ruperto and E. Alexeeva and V. Chasnyk and R. Schneider and G. Horneff and H.-I. Huppertz and K. Minden and K. Onel and L. Zemel and A. Martin and I. Kon{\'e}-Paut and A. Siamopoulou-Mavridou and C.A. Silva and B. Porter-Brown and K.N. Bharucha and H.I. Brunner and {De Benedetti}, F. and (PRCSG), {for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group}",

note = "Export Date: 7 February 2020",

year = "2019",

doi = "10.3899/jrheum.180795",

language = "English",

volume = "46",

pages = "1117--1126",

journal = "Journal of Rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology",

number = "9",

}

TY - JOUR

T1 - Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis

AU - Pardeo, M.

AU - Wang, J.

AU - Ruperto, N.

AU - Alexeeva, E.

AU - Chasnyk, V.

AU - Schneider, R.

AU - Horneff, G.

AU - Huppertz, H.-I.

AU - Minden, K.

AU - Onel, K.

AU - Zemel, L.

AU - Martin, A.

AU - Koné-Paut, I.

AU - Siamopoulou-Mavridou, A.

AU - Silva, C.A.

AU - Porter-Brown, B.

AU - Bharucha, K.N.

AU - Brunner, H.I.

AU - De Benedetti, F.

AU - (PRCSG), for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group

N1 - Export Date: 7 February 2020

PY - 2019

Y1 - 2019

U2 - 10.3899/jrheum.180795

DO - 10.3899/jrheum.180795

M3 - Article

VL - 46

SP - 1117

EP - 1126

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 9

ER -

Access to Document

10.3899/jrheum.180795

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071719321&doi=10.3899%2fjrheum.180795&partnerID=40&md5=5f764e0b9f58c7410eb1f7048e80dfb5

Projects

GASLINI - SCIENZE PEDIATRICHE, CHIRURGIA E NEONATOLOGIA

Project: Other project

Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis

Cite this

Access to Document

Related content

Projects

GASLINI - SCIENZE PEDIATRICHE, CHIRURGIA E NEONATOLOGIA